Saving lives through innovative antimicrobial solutions
Antibiotic overprescription has led to a rise in antimicrobial resistance, posing a clear and present danger to modern medicine and worldwide health. Arkstone empowers the healthcare community with tools to make informed medical decisions and reduce that threat.
Our commitment to combatting antimicrobial resistance and saving lives
To save as many lives as possible by reducing the global spread of antimicrobial-resistant bacteria and the misuse of antibiotics through continued education, advanced technology, and guidance to the medical community.
Worldwide annual deaths due to antimicrobial resistance.
Review on Antimicrobial Resistance, 2014
Up to 50% of antibiotics prescribed in the U.S. are unnecessary or inappropriate.
CDC, 2024
AMR infections add $20 billion annually to U.S. healthcare costs.
CDC
By 2050, drug-resistant infections could cause 10 million deaths annually if not controlled.
WHO, 2024
Leading the future of antimicrobial stewardship
At Arkstone, we are proud to support over 150 laboratories worldwide in their antimicrobial stewardship efforts. Our AI-powered solutions enhance clinical decision-making, ensuring better patient outcomes and optimized resource use. With a commitment to innovation and excellence, we are transforming the landscape of infectious disease management.
Transforming antimicrobial stewardship together
Our partnership with ARCHIMED enhances our capabilities in antimicrobial stewardship. Together, we are setting new standards in clinical decision support.
Science & Research Team
Meet the dedicated professionals driving our mission forward
Alicia Rendon
Director of Quality Assurance
LinkedIn
Dr. Juan Carlos Gómez de la Torre
Director of Molecular Informatics
Jen MacDermott
Quality Assurance Manager
Dr. Carlos Lencinas
Quality Assurance Manager
Dr. Miguel Hueda Zavaleta
Quality Assurance Manager
LinkedIn
Colleen Gross
Quality Assurance Manager
LinkedIn
Sheri Lundblad
Quality Assurance Manager
Stephanie Allman
Quality Assurance Manager
Diana Minchón Vizconde
Quality Assurance Manager
Schedule your demo
Experience the future of antimicrobial stewardship with our interactive demo today.
Latest insights and updates
Stay informed with our featured press releases.
Arkstone Launches Arkstone Next, Bringing Infectious Disease Expertise to Clinics, Urgent Care and Nursing HomesExpert-in-the-loop AI helps clinicians choose the right antibiotic, or none at all, where no infectious disease specialist is available
Arkstone’s AI Clinical Decision Support Helps Treat Over 1 Million PatientsThe Arkstone platform has been used by doctors across the USA to diagnose and treat diseases in over 1 million patients, a major milestone reached in October 2025. The milestone underscores Arkstone’s leadership in machine learning (ML) and artificial intelligence (AI)-driven infectious disease clinical guidance and its expanding partnerships across the U.S. and around the world.
Arkstone Announces RightDose, a Groundbreaking Enhancement to Ensure Proper Antimicrobial PrescribingThis innovative feature addresses the complexities healthcare providers face when dosing for different age groups and accommodating reduced renal and hepatic function